Myelodysplastic–myeloproliferative diseases
From Infogalactic: the planetary knowledge core
| Myelodysplastic-myeloproliferative diseases | |
|---|---|
| Classification and external resources | |
| Specialty | Lua error in Module:Wikidata at line 446: attempt to index field 'wikibase' (a nil value). |
| Patient UK | Myelodysplastic–myeloproliferative diseases |
| MeSH | D054437 |
Myelodysplastic–myeloproliferative diseases are a category of hematological malignancies disorders created by the World Health Organization which have characteristics of both myelodysplastic and myeloproliferative conditions.
When a hematological malignancy is characterised by normal differentiation of cells of myeloid cell line, it is referred to as myeloproliferative. On the other hand, when there is abnormal differentiation of cells of myeloid cell line, it is referred to as myelodysplastic.
External links
- http://www.meb.uni-bonn.de/cancer.gov/CDR0000334473.html
- http://www.cancer.org/docroot/CRI/content/CRI_2_4_1X_What_is_myelodysplastic_syndrome_65.asp
- http://www.cancer.gov/cancertopics/pdq/treatment/mds-mpd/Patient
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This oncology article is a stub. You can help Wikipedia by expanding it. |
